D-dimer measured at first venous thromboembolism is associated with future risk of cancer.
K.G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway olga.gran@uit.no.
Olga V
OV
Gran
K.G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.|Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
Sigrid K
SK
Brækkan
K.G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
Benedikte
B
Paulsen
K.G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
Hanne
H
Skille
K.G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.|Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
John-Bjarne
JB
Hansen
D014408:Biomarkers, Tumor / Q000097:blood; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000209:etiology*; D018570:Risk Assessment; D054556:Venous Thromboembolism / Q000097:blood / Q000150:complications* / Q000175:diagnosis
D014408:Biomarkers, Tumor; D005338:Fibrin Fibrinogen Degradation Products; C036309:fibrin fragment D
D-dimer; cancer; disorders of coagulation and fibrinolysisl; venous thrombosis